Midwest Investor Startup Studio Reveals Top Tips for Attracting Talent in a Tight Market Columbus, OH—August 21, 2018—Columbus’ growing startup community combined with a lower than average unemployment rate is… Read more
Posted by Rev1 Staff in #Startup Buzz
I’m excited to share that four Rev1 Ventures clients are among the 36 Columbus-based companies which made the 2018 Inc. 5000 list of the country’s fastest-growing, privately held companies in… Read more
Posted by Kristy Campbell in #Startup Buzz
Millions of people are working in the gig economy. Reports indicate that in the U.S. from 4 to more than 30 percent of workers doing jobs that range from driving,… Read more
Posted by Bob Wiggins in #Startup Buzz
What do lunar astronauts, Marines, and shoppers at a local mall have in common? They may all benefit from the unique solutions from Ubihere, a spinout from The Ohio State… Read more
Posted by David Bergeron in #Startup Buzz
Equity compensation is a tool for cash-strapped startups to attract, retain, and motivate key employees with a future interest in the company. Equity compensation can also be an effective method… Read more
Posted by Miranda Morgan in The Hard Stuff
What if you didn’t have to drive to work every day? What if instead, you rode in a safe, clean, comfortable minivan driven by a well-vetted and well-paid driver who… Read more
Posted by Bob Wiggins in #Startup Buzz
In medicine, pathologists are known as the doctors’ doctors. Whether the task at hand is to diagnose an individual patient or to study the influence of a particular cell on… Read more
Posted by Wayne Embree in #Startup Buzz
Running a startup is hard. Mistakes are inevitable, but many missteps are avoidable. Here are 5 common mistakes entrepreneurs should avoid. 1. Never sign an agreement without reading it thoroughly…. Read more
Posted by Bob Wiggins in Getting Started
Biotherapeutics is the fastest growing sector in the pharmaceutical industry. McKinsey reports an expansive outlook for biologics. There are already more than 200 approved therapies on the market, another 1,500-plus… Read more
Posted by David Bergeron in #Startup Buzz
